It is thus possible that Mx1 antiviral activity acts in combination with other ISG that are not expressed in the four sensitive tumor cell lines that produce type I IFN and express Mx1 in response to MV, whereas these required ISG are expressed in the seven insensitive tumor cell lines, thereby blocking MV replication. The gene discussed is MX1; the disease is neoplasm.